Dong, Jing
Buradagunta, Christopher Staffi
Zhang, Tao
Spellman, Stephen
Bolon, Yung-Tsi
DeZern, Amy E.
Gadalla, Shahinaz M.
Deeg, H. Joachim
Nazha, Aziz
Cutler, Corey
Cheng, Chao
Urrutia, Raul
Auer, Paul
Saber, Wael
Article History
Received: 19 December 2022
Accepted: 26 February 2023
First Online: 10 March 2023
Declarations
:
: The study was approved by the Institutional Review Board of CIBMTR and conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: Dr. DeZern reports payment or honoraria from Taiho for Myeloid teaching and participation on a Data Safety Monitoring Board or Advisory Board with Geron, Novartis, Gilead, BMS – all for novel therapeutics and not relevant to this manuscript.